Stantec (STN)
Financials 
Technical Analysis 
Aug 13, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Stantec Inc. has shown resilience in the face of AI-related concerns among engineering consultants, demonstrating improved margins compared to the last quarter. Although organic growth fell slightly short of expectations, the company has reaffirmed its guidance for the full year, anticipating enhanced growth as larger projects begin to ramp up. Analysts express confidence in Stantec's balance sheet relative to its peers, emphasizing short-term capital deployment aimed at fostering growth. The stock currently trades at a price-to-earnings ratio of 15, which is attractive given its projected 15% growth rate, indicating it offers good value to investors. With a yield of 0.93% and a favorable price target of $107.98, Stantec appears well-positioned in the market.
- «
- ‹
- 1
- ›
- »
Popular Articles
Stantec (STN) Frequently Asked Questions
What is Stantec stock symbol?
Stantec is a OTC stock, trading under the symbol STN (previously STN-N on Stockchase) on the undefined (undefined). It is usually referred to as or STN
Is Stantec a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on STN (previously STN-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Stantec.
Is Stantec a good investment or a top pick?
Stantec was recommended as a Top Pick by Greg Newman on 2026-05-28. Read the latest stock experts ratings for Stantec.
Why is Stantec stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Stantec.
Is Stantec worth watching?
Stantec is covered by Stockchase experts and is worth watching.
All engineering consultants have come down on AI fears. Beat last quarter on higher margins. Organic growth missed a bit, but kept full-year guide. Company expects organic growth to improve this year as larger projects ramp up.
(Analysts’ price target is $107.98)Prefers its balance sheet to peers, more near-term capital deployment to spur growth. Trades at 15x PE, for 15% growth. Very good value. Yield is 0.93%.